LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study

Clinical trial NCT07556640 · RECRUITING

Trial details

NCT number: NCT07556640
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Stage IV Peritoneal Metastases From Gastric Cancer Gastric or Esophagogastric Junction Adenocarcinoma

Start date: 2026-04-17
Primary completion: 2028-04-30
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.